ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,202 | -31.6% | 19,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,217 | -67.8% | 19,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $10,000 | -9.1% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | 0.0% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | – | 19,000 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 19,000 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 19,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $1,000,000 | 0.0% | 19,000 | 0.0% | 0.13% | -10.9% |
| Q4 2020 | $1,000,000 | +6566.7% | 19,000 | 0.0% | 0.15% | +4800.0% |
| Q3 2020 | $15,000 | +50.0% | 19,000 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $10,000 | +42.9% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |